Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for Recursion Pharmaceuticals, INC., €73k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
David Hallett: trading record in brief
David Hallett discloses dealings in Recursion Pharmaceuticals, Inc. to SEC (Form 4). Between 6 February 2026 and 17 August 2026, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 18 August 2026, reports a share grant of €73k in Recursion Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to David Hallett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
26,657 shares@ US$3.160.0041% mcap67.5% of flowClass A Common StockSEC:0002006495-26-000012:0
11,908 shares@ US$3.4932.5% of flowClass A Common StockSEC:0001601830-26-000022:0
502,064 shares0Class A Common StockSEC:0001601830-26-000012:0
3 of 3 declarations
